Harbor Light Capital Partners is a venture capital firm in Keene that prefers to invest in companies in the healthcare, innovative and disruptive technology sectors. Founded 1991 in Keene, New Hampshire, United States, the firm invests in early stage ventures. The notable investment portfolio of Harbor Light Capital Partners includes Carmell Therapeutics, Courtagen Life Sciences, Senet, Carmell Therapeutics, Terascala, EnerTrac, Draker, and Vets First Choice. As of February 2020, Harbor Light Capital Partners has made 15 investments. Their most recent investment was on July 11, 2017, when Carmell Therapeutics raised $4M. Harbor Light Capital Partners has had 1 exit, which was Eggrock Partners.The company typically invests between $1-$5 million.
Documentaries, videos and podcasts
Courtagen Life Sciences
Vets First Choice